Conference Coverage

Most patients off transfusions after gene therapy for thalassemia

Publish date: March 30, 2018

 

REPORTING FROM THE 2018 BMT TANDEM MEETINGS

SOURCE: Walters, M et al. 2018 BMT Tandem Meetings, Abstract 62.

Pages

Recommended Reading

Gene therapy for hemophilia A gets fast-track review
MDedge Hematology and Oncology
States strive to curb costs for a crucial – but exorbitant – hemophilia treatment
MDedge Hematology and Oncology
Hemophilia A treatment gains approval in Europe
MDedge Hematology and Oncology
Of ‘miracles’ and money: Why hemophilia drugs are so expensive
MDedge Hematology and Oncology
Von Willebrand Disease: Approach to Diagnosis and Management
MDedge Hematology and Oncology
Bleeding episodes more common in boys with VWD
MDedge Hematology and Oncology
Deaths in patients on emicizumab
MDedge Hematology and Oncology
Product approved for hemophilia patients in Japan
MDedge Hematology and Oncology
PK dosing software available in US
MDedge Hematology and Oncology
EC approves emicizumab for hemophilia A with inhibitors
MDedge Hematology and Oncology